A case of relapsing chronic eosinophilic pneumonia treated by Omalizumab

Chronic eosinophilic pneumonia (CEP) is an idiopathic disorder characterized by an abnormal accumulation of eosinophils in the pulmonary interstitial and alveolar spaces. Although many patients respond very well to treatment by steroids, some suffer from disease relapse. There aren't many treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Nehme, Ralph, Samaha, Daisy, Al Haddad, Youssef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792900/
https://www.ncbi.nlm.nih.gov/pubmed/36583062
http://dx.doi.org/10.1016/j.rmcr.2022.101796
_version_ 1784859735645749248
author Nehme, Ralph
Samaha, Daisy
Al Haddad, Youssef
author_facet Nehme, Ralph
Samaha, Daisy
Al Haddad, Youssef
author_sort Nehme, Ralph
collection PubMed
description Chronic eosinophilic pneumonia (CEP) is an idiopathic disorder characterized by an abnormal accumulation of eosinophils in the pulmonary interstitial and alveolar spaces. Although many patients respond very well to treatment by steroids, some suffer from disease relapse. There aren't many treatment alternatives for steroid dependent patients or patients who are steroid intolerant because of their side effects. In the following article, we report the case of a 68 years old lady suffering from a relapsing CEP and severe osteoporosis successfully treated with Omalizumab.
format Online
Article
Text
id pubmed-9792900
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-97929002022-12-28 A case of relapsing chronic eosinophilic pneumonia treated by Omalizumab Nehme, Ralph Samaha, Daisy Al Haddad, Youssef Respir Med Case Rep Case Report Chronic eosinophilic pneumonia (CEP) is an idiopathic disorder characterized by an abnormal accumulation of eosinophils in the pulmonary interstitial and alveolar spaces. Although many patients respond very well to treatment by steroids, some suffer from disease relapse. There aren't many treatment alternatives for steroid dependent patients or patients who are steroid intolerant because of their side effects. In the following article, we report the case of a 68 years old lady suffering from a relapsing CEP and severe osteoporosis successfully treated with Omalizumab. Elsevier 2022-12-16 /pmc/articles/PMC9792900/ /pubmed/36583062 http://dx.doi.org/10.1016/j.rmcr.2022.101796 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Nehme, Ralph
Samaha, Daisy
Al Haddad, Youssef
A case of relapsing chronic eosinophilic pneumonia treated by Omalizumab
title A case of relapsing chronic eosinophilic pneumonia treated by Omalizumab
title_full A case of relapsing chronic eosinophilic pneumonia treated by Omalizumab
title_fullStr A case of relapsing chronic eosinophilic pneumonia treated by Omalizumab
title_full_unstemmed A case of relapsing chronic eosinophilic pneumonia treated by Omalizumab
title_short A case of relapsing chronic eosinophilic pneumonia treated by Omalizumab
title_sort case of relapsing chronic eosinophilic pneumonia treated by omalizumab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792900/
https://www.ncbi.nlm.nih.gov/pubmed/36583062
http://dx.doi.org/10.1016/j.rmcr.2022.101796
work_keys_str_mv AT nehmeralph acaseofrelapsingchroniceosinophilicpneumoniatreatedbyomalizumab
AT samahadaisy acaseofrelapsingchroniceosinophilicpneumoniatreatedbyomalizumab
AT alhaddadyoussef acaseofrelapsingchroniceosinophilicpneumoniatreatedbyomalizumab
AT nehmeralph caseofrelapsingchroniceosinophilicpneumoniatreatedbyomalizumab
AT samahadaisy caseofrelapsingchroniceosinophilicpneumoniatreatedbyomalizumab
AT alhaddadyoussef caseofrelapsingchroniceosinophilicpneumoniatreatedbyomalizumab

Ejemplares similares